𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

✍ Scribed by Lockwood G. Taylor; Steven E. Canfield; Xianglin L. Du

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
177 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Androgen deprivation therapy increases c
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec

Does androgen-deprivation therapy accele
Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer? : A conceptual review
✍ Kathryn Bylow; Supriya G. Mohile; Walter M. Stadler; William Dale πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

## Abstract The majority of men with prostate cancer are aged β‰₯65 years. Men, as they age, are more likely to suffer from impaired physical function. The standard treatment for recurrent prostate cancer is androgen‐deprivation therapy (ADT). Well‐established toxicities from ADT include lean weight

Natural history of bone complications in
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy
✍ Tracey L. Krupski; Matthew R. Smith; Won Chan Lee; Chris L. Pashos; Jane Brandma πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Background: As evidence accumulates in favor of androgen deprivation therapy (adt) in patients with recurrent or metastatic prostate carcinoma, concern has increased regarding bone loss associated with therapeutic hypogonadism. the current study described the natural history of bone complication

Significant associations of prostate can
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
✍ Bo-Ying Bao; Jiunn-Bey Pao; Chun-Nung Huang; Yeong-Shiau Pu; Ta-Yuan Chang; Yu-H πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

## Abstract Androgen‐deprivation therapy (ADT) is the most common therapy for advanced prostate cancer, but the prognosis significantly differs among individuals. In this study, we evaluated recently identified 19 prostate cancer susceptibility variants as prognostic predictors for the survival aft

Pretreatment prostate-specific antigen v
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy
✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a